Professional
Added to YB: 2026-02-13
Pitch date: 2026-02-08
SRT.DE [neutral]
Sartorius Aktiengesellschaft
+3.44%
current return
Author Info
No bio for this author
Company Info
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cytometry; ultrafiltration solutions; syringe, membrane, glass and quartz microfiber, clarification, syringeless, and in-line filters; and lab chromatography, and filters and blotting papers.
Market Cap
EUR 14.6B
Pitch Price
EUR 186.00
Price Target
N/A
Dividend
0.32%
EV/EBITDA
22.35
P/E
N/A
EV/Sales
5.56
Sector
Life Sciences Tools and Services
Category
growth
SGA International Growth Portfolio Holding: Sartorius Aktiengesellschaft
SRT.DE (holding update): Q3 sales +10% CC, EPS +27% on bioprocessing recovery (80% sales, +11% CC growth) as consumables rebound from post-pandemic destocking & equipment stabilizes. Lab products (R&D) weak. Mgmt raised FY guidance on improving biopharma outlook. High recurring revenue, strong position, innovation support high-teens EPS growth est. over 3yrs.
Read full article (1 min)